30 Day Trial

ChoiceSpine Announces First Clinical Use of HAWKEYE Ti VBR

Share:

ChoiceSpine announced the initial clinical use of the HAWKEYE® Ti vertebral body replacement, its first 3D-printed device.

HAWKEYE Ti received FDA 510(k) clearance in early 4Q17. The line includes small and large footprint designs from 10mm to 60mm tall, with 0° or 8° lordosis. Coarse nanosurfaces encourage bony growth throughout the device. HAWKEYE is to be used with autograft and/or allograft; earlier this year, ChoiceSpine launched its own line of orthobiologics, including allograft, synthetic bone graft and amnion offerings.

Source: ChoiceSpine

ChoiceSpine HAWKEYE Ti VBR
Image courtesy of ChoiceSpine LP